Europe Biopharmaceutical Processing Equipment and Consumables Market (2025-2032)
The Europe Biopharmaceutical Processing Equipment and Consumables Market is expected to grow at a CAGR of 9.7% from 2025 to 2032 to reach $25.02 billion by 2032.
- Published
- Jan 2025
- Pages
- 150
- Format
- PDF + Excel
- Report ID
- MRHC - 104868
- Base year
- 2024
- 2032 · FORECAST
- $25.02B
- 2032
- $25.02B
- CAGR 2025–2032
- 9.7%
2024 baseline · 2025–2032 forecast at 9.7% CAGR · hover a bar for the value
Key highlights
Among the Product Types, The Filtration Systems Segment is Expected to Account for the Largest Share of the Market in 2025
Among the Applications, The Commercial Bioproduction Segment is Projected to Grow at the Highest CAGR Over the Forecast Period
Germany: To Account for the Largest Market Share in 2025
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 25.02 billion |
| CAGR (2025–2032) | 9.7% |
| Format | PDF, Excel & Cloud Portal · 150 pages |
| Segments Covered | By Product Type {Filtration, Chromatography: Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services · By Application: Vaccine, mAb, R&D · By End User |
| Key Companies | Sartorius AG, Merck KGaA, Eppendorf AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc, Repligen Corporation, Danaher Corporation |
Report overview
Segments covered: product type {filtration, chromatography, application, end user.
Biopharmaceutical processing involves the study of the discovery, development, and processing of complex medicines using living cells and organisms. Biopharmaceuticals include vaccines, whole blood and blood components, gene therapies, recombinant therapeutic proteins, and somatic cells.
Biopharmaceutical processing uses equipment such as filtration systems, chromatography equipment and consumables, bioreactors, cell culture systems, mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, biosafety cabinets, and other equipment like membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors for commercial and research-based bioproduction.
The growth of this market is driven by factors such as the growth of the biopharmaceuticals market, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment. However, biopharmaceuticals' complex development and manufacturing process restrain the market’s growth.
Furthermore, the shift towards Bioprocessing 4.0 and the rising adoption of personalized medicine are expected to offer significant market growth opportunities. The intensive capital requirements for biopharmaceutical production pose a major challenge to the market’s growth. The trends for the Europe biopharmaceutical processing equipment and consumables market are the use of disposable processing equipment for commercial production and rising focus on continuous bioprocessing.
Report infographic
Market dynamics
1 factors across 1 forceGrowing Focus on Continuous Bioprocessing to Drive the Growth of this Market
For a long time, batch/fed-batch mode has dominated the manufacturing of biopharmaceuticals in Europe. However, it has some limitations - it requires additional instruments for feedback control and is costly operation costs compared to continuous bioprocessing. In continuous bioprocessing, the process is performed at a single location without interruption, as there is a continuous flow of raw materials in and out of the bioreactor with the processing of the intermediate or final product—in contrast to batch culture—in which specific quantity of product is produced in a discrete volume during the same cycle of manufacture, and the process is frequently segmented into many individual steps that are often performed at separate facilities.
Moreover, continuous processing produces a quality end product with no variation and offers steady-state operation, reduced equipment size, streamlined process flow, and reduced capital costs. Due to the growing demand for innovative and complex therapies and the growing competition in the European biopharmaceuticals market, biopharmaceutical manufacturers are reconsidering manufacturing methods (shifting from batch to continuous manufacturing). Although batch manufacturing is preferred, continuous manufacturing is increasingly accepted in the pharmaceutical industry due to its commercial advantages.
Table of contents
11 chapters · 108 sections · 150 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product Type | Filtration Systems | — |
| By Application | Pharmaceutical and Biopharmaceutical Companies | Commercial bioproduction |
By Product Type
- The filtration systems segment is expected to account for the largest share of the Europe biopharmaceutical processing equipment and consumables market.
- The process of filtration is the basic requisite across all stages of bioproduction.
- Filtration is commonly used in biopharmaceutical processing for separating components.
- It is used in various downstream operations, such as clarification, filtration of intermediates, critical final filling applications, or upstream processing for sterilizing-grade filtration of cell culture media.
- The largest share of this segment is attributed to the frequent use of filtration at every step in bioprocessing and technological advancements in filtration technologies.
By Application
- The commercial bioproduction segment is estimated to grow at the highest CAGR during the forecast period.
- Growing initiatives supporting the adoption of biopharmaceuticals, rising biopharmaceutical manufacturing outsourcing, and accelerated developments in personalized therapies are some drivers for this segment's growth.
- Trelleborg AB (Sweden) expanded its biopharmaceutical manufacturing capabilities to extend capabilities in the future in Europe.
- This is likely to enhance the demand for bioprocessing equipment and consumables for the commercial bioproduction of monoclonal antibodies (mAbs), vaccines, gene therapies, and recombinant protein-based are the factors contributing to the largest share of this segment.
- The Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Market in 2025
- The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of Europe Biopharmaceutical Processing Equipment and Consumables market.
- The capacity expansion of biopharmaceutical manufacturers and the growing adoption of biopharmaceutical processing equipment for bioproduction is the key factor for the largest market share.
- The development and manufacturing of biopharmaceuticals are gaining pace.
- Thus, growing manufacturing by biopharmaceutical companies has driven the demand for biopharmaceutical processing equipment and consumables.
Geographic analysis
Europe
Largest shareIn 2025, Germany is expected to account for the largest share of the Europe biopharmaceutical processing equipment and consumables market. The large share is primarily attributed to an increase in pharmaceutical export, government grants, and funding to biotech and biopharmaceutical companies' expansion to meet the increasing market demand. For instance, in 2021, BioNTech SE (Germany) opened a new manufacturing facility in Hamburg, Germany, which acts as a manufacturing and storage facility for BioNTech and Pfizer’s COVID-19 vaccine. In 2021, Baxter Biopharma Solutions LLC (U.S.) invested USD 100 million to expand the fill-finish capabilities of their plant in Halle/Westfalen, Germany. U. K. Germany: To Account for the Largest Market Share in 2025 Europe Biopharmaceutical Processing Equipment and Consumables Market Size & Trend Analysis, by Product Type Filtration Systems Chromatography Equipment and Consumables Chromatography Consumables Reusable Bioreactors Disposable/Single-use Bioreactors Cell Culture Media Cell Culture Media, by Physical Form Dry Powder Media Liquid Media Off-the-Shelf Media Custom Media Chemically Defined Media Natural Media Commercial Bioproduction Vaccine Manufacturing Monoclonal Antibody Production Recombinant Protein Production Cell and Gene Therapy Production Pharmaceutical and Biopharmaceutical Companies Contract Development and Manufacturing Organizations (CDMOs) Academia and Research Institutes France Italy Spain Switzerland Denmark Ireland Belgium Rest of Europe (RoE)
Competitive landscape
- Sartorius AG
- Merck KGaA
- Eppendorf AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc
- Repligen Corporation
- Danaher Corporation
Frequently asked questions
This study offers a detailed assessment of the Europe biopharmaceutical processing equipment and consumables market, including the market size & forecast for various segmentation like mode of product type, application, and end user. The Europe biopharmaceutical processing equipment and consumables market studied in this report also involve the value analysis of various segments and sub-segments of biopharmaceutical processing equipment and consumables at country levels.
Cite this report
Meticulous Research. (2025). Europe Biopharmaceutical Processing Equipment and Consumables Market - Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104868). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/europe-biopharmaceutical-processing-equipment-and-consumables-market-5551